Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endoscopic Ultrasound-guided Radiofrequency Ablation as a Novel Treatment Option Compared With Adrenalectomy in Left-sided Primary Aldosteronism

NCT05368090 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.

NCT NCT05368090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05368090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endoscopic Ultrasound-guided Radiofrequency Ablation as a Novel Treatment Option Compared With Adrenalectomy in Left-sided Primary Aldosteronism
Lead sponsor
Haukeland University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
June 3, 2022
Completion date
December 31, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aldosterone-producing adenoma, hypercortisolism, primary aldosteronism